Instead of using the Edison machines, Carreyrou discovered that Theranos was using traditional testing machines and not telling its customers or investors. In 2015, the Wall Street Journal published an article by John Carreyrou exposing Theranos for not using its own technology to run tests on the blood samples they collected from individuals. Theranos also partnered with Walgreens and in 2013, the company opened 40 Theranos wellness centers in Walgreens stores across Arizona. As Theranos rose to prominence, the company secured partnerships with healthcare companies including Capital Blue Cross and Cleveland Clinic. Theranos raised over $700 million from investors, and was valued at $9 billion in 2014. Holmes’ promise of revolutionizing the healthcare industry won over many prominent investors, companies and the media. Holmes, who often spoke of her fear of needles, envisioned people walking into stores like Walgreens and being screened for hundreds of diseases efficiently and painlessly with the Edison. Holmes had a vision of “democratizing healthcare” with Theranos technology and wanted the Theranos machines - dubbed “Edison” after Thomas Edison - to be available in Theranos wellness centers across the United States. Theranos’ goal was to perform various diagnostic tests off a single drop of blood from an individual’s fingertip. She dropped out of Stanford during her sophomore year to focus her attention on developing Theranos. Holmes was a student at Stanford beginning in 2002 and studied chemical engineering. Elizabeth Holmes is the founder and former CEO of the now defunct healthcare technology company, Theranos.
0 kommentar(er)
